Albumin-Paclitaxel

DRUG4 trials

Sponsors

Ruijin Hospital, CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University, Henan Cancer Hospital

Conditions

Advanced Solid TumorBreast Cancer Early Stage Breast Cancer (Stage 1-3)Gastric CancerHead and Neck Squamous Cell Carcinoma

Phase 1

A Study of Mitoxantrone Hydrochloride Liposome Injection Combination Therapy in Chinese Patients With Advanced Solid Tumors

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Advanced Solid Tumor

Start: 2022-04-30End: 2025-03-31Target: 116Updated: 2022-04-25

Phase 2

Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis

Ruijin HospitalGastric Cancer

Start: 2021-08-07End: 2024-08-01Target: 60Updated: 2021-08-24

Penpulimab Combined With Chemotherapy for Neoadjuvant and Adjuvant Therapy in Patients With Resectable HNSCC

RecruitingNCT06081673

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityHead and Neck Squamous Cell Carcinoma

Start: 2023-10-30End: 2026-10-30Target: 72Updated: 2023-10-13

SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC

RecruitingNCT06927180

Henan Cancer HospitalBreast Cancer Early Stage Breast Cancer (Stage 1-3)

Start: 2025-04-16End: 2030-12-01Target: 180Updated: 2025-06-23

Related Papers

A phase II clinical study of neoadjuvant penpulimab combined with chemotherapy for patients with locoregionally advanced, resectable squamous cell carcinoma of the head and neck.

Journal of Clinical Oncology2025-05-281 citations